Your request to link to rcsb for GRIK1


  • 1TXF: crystal structure of the glur5 ligand binding core in complex with glutamate at 2.1 angstrom resolution (10.1016/J.NEURON.2005.01.031 )
  • 1VSO: crystal structure of the ligand-binding core of iglur5 in complex with the antagonist (s)-atpo at 1.85 a resolution (10.1074/JBC.M700137200 )
  • 1YCJ: crystal structure of the kainate receptor glur5 ligand-binding core in complex with (s)-glutamate (10.1016/J.FEBSLET.2005.01.012 )
  • 2F34: crystal structure of the glur5 ligand binding core dimer with ubp310 at 1.74 angstroms resolution (10.1523/JNEUROSCI.0123-06.2005 )
  • 2F35: crystal structure of the glur5 ligand binding core with ubp302 at 1.87 angstroms resolution (10.1523/JNEUROSCI.0123-06.2005 )
  • 2F36: crystal structure of the glur5 ligand binding core dimer with glutamate at 2.1 angstroms resolution (10.1523/JNEUROSCI.0123-06.2005 )
  • 2OJT: structure and mechanism of kainate receptor modulation by anions (10.1016/J.NEURON.2007.02.025 )
  • 2PBW: crystal structure of the ligand-binding core of iglur5 in complex with the partial agonist domoic acid at 2.5 a resolution (10.1074/JBC.M700137200 )
  • 2QS1: crystal structure of the glur5 ligand binding core dimer in complex with ubp315 at 1.80 angstroms resolution (10.1016/J.NEUROPHARM.2010.06.002 )
  • 2QS2: crystal structure of the glur5 ligand binding core dimer in complex with ubp318 at 1.80 angstroms resolution (10.1016/J.NEUROPHARM.2010.06.002 )
  • 2QS3: crystal structure of the glur5 ligand binding core dimer in complex with ubp316 at 1.76 angstroms resolution (10.1016/J.NEUROPHARM.2008.08.016 )
  • 2QS4: crystal structure of the glur5 ligand binding core dimer in complex with ly466195 at 1.58 angstroms resolution (10.1016/J.NEUROPHARM.2010.06.002 )
  • 2WKY: crystal structure of the ligand-binding core of glur5 in complex with the agonist 4-ahcp (10.1021/JM900565C )
  • 2ZNS: crystal structure of the ligand-binding core of the human ionotropic glutamate receptor, glur5, in complex with glutamate (10.1016/J.JMB.2011.08.043 )
  • 2ZNT: crystal structure of the ligand-binding core of the human ionotropic glutamate receptor, glur5, in complex with a novel selective agonist, dysiherbaine (10.1016/J.JMB.2011.08.043 )
  • 2ZNU: crystal structure of the ligand-binding core of the human ionotropic glutamate receptor, glur5, in complex with a novel selective agonist, neodysiherbaine a (10.1016/J.JMB.2011.08.043 )
  • 3C31: crystal structure of glur5 ligand-binding core in complex with lithium at 1.49 angstrom resolution (10.1016/J.NEURON.2008.04.001 )
  • 3C32: crystal structure of glur5 ligand-binding core in complex with sodium at 1.72 angstrom resolution (10.1016/J.NEURON.2008.04.001 )
  • 3C33: crystal structure of glur5 ligand-binding core in complex with potassium at 1.78 angstrom resolution (10.1016/J.NEURON.2008.04.001 )
  • 3C34: crystal structure of glur5 ligand-binding core in complex with rubidium at 1.82 angstrom resolution (10.1016/J.NEURON.2008.04.001 )
  • 3C35: crystal structure of glur5 ligand-binding core in complex with cesium at 1.97 angstrom resolution (10.1016/J.NEURON.2008.04.001 )
  • 3C36: crystal structure of glur5 ligand-binding core in complex with ammonium ions at 1.68 angstrom resolution (10.1016/J.NEURON.2008.04.001 )
  • 3FUZ: crystal structure of the human glutamate receptor, glur5, ligand- binding core in complex with l-glutamate in space group p1 (10.1016/J.JMB.2011.08.043 )
  • 3FV1: crystal structure of the human glutamate receptor, glur5, ligand- binding core in complex with dysiherbaine in space group p1 (10.1016/J.JMB.2011.08.043 )
  • 3FV2: crystal structure of the human glutamate receptor, glur5, ligand- binding core in complex with neodysiherbaine a in space group p1 (10.1016/J.JMB.2011.08.043 )
  • 3FVG: crystal structure of the human glutamate receptor, glur5, ligand- binding core in complex with msviii-19 in space group p1 (10.1016/J.JMB.2011.08.043 )
  • 3FVK: crystal structure of the human glutamate receptor, glur5, ligand- binding core in complex with 8-deoxy-neodysiherbaine a in space group p1 (10.1016/J.JMB.2011.08.043 )
  • 3FVN: crystal structure of the human glutamate receptor, glur5, ligand- binding core in complex with 9-deoxy-neodysiherbaine a in space group p1 (10.1016/J.JMB.2011.08.043 )
  • 3FVO: crystal structure of the human glutamate receptor, glur5, ligand- binding core in complex with 8-epi-neodysiherbaine a in space group p1
  • 3GBA: x-ray structure of iglur5 ligand-binding core (s1s2) in complex with dysiherbaine at 1.35a resolution (10.1074/JBC.M808547200 )
  • 3GBB: x-ray structure of iglur5 ligand-binding core (s1s2) in complex with msviii-19 at 2.10a resolution (10.1074/JBC.M808547200 )
  • 3S2V: crystal structure of the ligand binding domain of gluk1 in complex with an antagonist (s)-1-(2'-amino-2'-carboxyethyl)-3-[(2- carboxythien-3-yl)methyl]thieno[3,4-d]pyrimidin-2,4-dione at 2.5 a resolution (10.1021/JM2004078 )
  • 4DLD: crystal structure of the gluk1 ligand-binding domain (s1s2) in complex with the antagonist (s)-2-amino-3-(2-(2-carboxyethyl)-5-chloro-4- nitrophenyl)propionic acid at 2.0 a resolution (10.1002/CMDC.201100599 )
  • 4E0X: crystal structure of the kainate receptor gluk1 ligand-binding domain in complex with kainate in the absence of glycerol (10.1016/J.NEUINT.2012.02.016 )
  • 4MF3: crystal structure of human grik1 complexed with a 6-(tetrazolyl)aryl decahydroisoquinoline antagonist (10.1016/J.BMCL.2013.09.045 )
  • 4QF9: structure of gluk1 ligand-binding domain (s1s2) in complex with (s)-2- amino-4-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-6-yl)butanoic acid at 2.28 a resolution (10.1021/ACSCHEMNEURO.5B00038 )
  • 4YMB: structure of the ligand-binding domain of gluk1 in complex with the antagonist cng10111 (10.1021/ACS.JMEDCHEM.5B00750 )
  • 5M2V: structure of gluk1 ligand-binding domain (s1s2) in complex with (2s, 4r)-4-(2-carboxyphenoxy)pyrrolidine-2-carboxylic acid at 3.18 a resolution (10.1021/ACS.JMEDCHEM.6B01516 )
  • 5MFQ: crystal structure of the gluk1 ligand-binding domain in complex with kainate and bpam-344 at 1.90 a resolution (10.1124/MOL.116.107599 )
  • 5MFV: crystal structure of the gluk1 ligand-binding domain in complex with kainate and bpam-521 at 2.18 a resolution (10.1124/MOL.116.107599 )
  • 5MFW: crystal structure of the gluk1 ligand-binding domain in complex with kainate and bpam-121 at 2.10 a resolution (10.1124/MOL.116.107599 )
  • 5NEB: structure of gluk1 ligand-binding domain (s1s2) in complex with lm-12b at 2.05 a resolution (10.1021/ACSCHEMNEURO.7B00201 )
  • 5NF5: structure of gluk1 ligand-binding domain (s1s2) in complex with cip-as at 2.85 a resolution (10.1021/ACSCHEMNEURO.7B00201 )
  • 6FZ4: structure of gluk1 ligand-binding domain in complex with n-(7-fluoro- 2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2h)-yl)-2- hydroxybenzamide at 1.85 a resolution (10.1021/ACSCHEMNEURO.8B00726 )
  • 6SBT: structure of gluk1 ligand-binding domain (s1s2) in complex with n-(7- (1h-imidazol-1-yl)-2,3-dioxo-6-(trifluoromethyl)-3,4- dihydroquinoxalin-1(2h)-yl benzamide at 2.3 a resolution (10.1021/ACSCHEMNEURO.9B00479 )